Skip to main content
Erschienen in: Current Hepatology Reports 4/2018

05.10.2018 | Portal Hypertension (J Gonzalez-Abraldes and E Tsochatzis, Section Editors)

Portal Cavernoma Cholangiopathy

verfasst von: Dominique-Charles Valla

Erschienen in: Current Hepatology Reports | Ausgabe 4/2018

Einloggen, um Zugang zu erhalten

Abstract

Purpose of Review

Portal cavernoma cholangiopathy is a rare condition, a proper recognition of which is critical. Solid data on this condition are scarce. This review aims at updating current knowledge on its definition, manifestations, diagnosis, and management.

Recent Findings

A consensus has been reached to prefer the denomination portal cavernoma cholangiopathy for the bile duct irregularities associated with portal cavernoma. Such irregularities are characterized by stenosis with or without dilatation and are mostly related to the impinging on bile duct lumen by portoportal collaterals. While bile duct irregularities are found in over 80% of patients with portal cavernoma, clinical manifestations, and complications (cholecystitis and biliary stones, but rarely cholestasis) occur in only 5–35% of them. Diagnosis can be and should be based on findings at magnetic resonance cholangiography and portography. Differential diagnosis includes primary and secondary sclerosing cholangitis, and cholangiocarcinoma. Asymptomatic patients may be managed expectantly. Endoscopic procedures are to be used in the first line for complications. Combined endoscopic and surgical approaches including portosystemic shunting can be considered in refractory or recurrent cases.

Summary

Portal cavernoma cholangiopathy mostly is a morphologic entity which is present in a majority of patients with portal cavernoma. The minority of patients with acute biliary complications should be treated as conservatively as possible. Late consequences of chronic cholestasis appear to be rare.
Literatur
1.
Zurück zum Zitat Chawla Y, Agrawal S. Portal cavernoma cholangiopathy – history, definition and nomenclature. J Clin Exp Hepatol. 2014;4:S15–7.CrossRef Chawla Y, Agrawal S. Portal cavernoma cholangiopathy – history, definition and nomenclature. J Clin Exp Hepatol. 2014;4:S15–7.CrossRef
2.
Zurück zum Zitat •• Dhiman RK, Saraswat VA, Valla DC, Chawla Y, Behera A, Varma V, et al. Portal cavernoma cholangiopathy: consensus statement of a working party of the Indian National Association for the study of the liver. J Clin Exp Hepatol. 2014;4:S2–S14 A landmark paper for the definition, pathogenesis, manifestations, diagnosis, and treatment of portal cavernoma cholangiopathy.CrossRef •• Dhiman RK, Saraswat VA, Valla DC, Chawla Y, Behera A, Varma V, et al. Portal cavernoma cholangiopathy: consensus statement of a working party of the Indian National Association for the study of the liver. J Clin Exp Hepatol. 2014;4:S2–S14 A landmark paper for the definition, pathogenesis, manifestations, diagnosis, and treatment of portal cavernoma cholangiopathy.CrossRef
3.
Zurück zum Zitat Bhatia V. Endoscopic retrograde cholangiography in portal cavernoma cholangiopathy – results from different studies and proposal for uniform terminology. J Clin Exp Hepatol. 2014;4:S37–43.CrossRef Bhatia V. Endoscopic retrograde cholangiography in portal cavernoma cholangiopathy – results from different studies and proposal for uniform terminology. J Clin Exp Hepatol. 2014;4:S37–43.CrossRef
4.
Zurück zum Zitat Kalra N, Shankar S, Khandelwal N. Imaging of portal cavernoma cholangiopathy. J Clin Exp Hepatol. 2014;4:S44–52.CrossRef Kalra N, Shankar S, Khandelwal N. Imaging of portal cavernoma cholangiopathy. J Clin Exp Hepatol. 2014;4:S44–52.CrossRef
5.
Zurück zum Zitat Chandra R, Kapoor D, Tharakan A, Chaudhary A, Sarin SK. Portal biliopathy. J Gastroenterol Hepatol. 2001;16:1086–92.CrossRef Chandra R, Kapoor D, Tharakan A, Chaudhary A, Sarin SK. Portal biliopathy. J Gastroenterol Hepatol. 2001;16:1086–92.CrossRef
6.
Zurück zum Zitat •• Llop E, de Juan C, Seijo S, Garcia-Criado A, Abraldes JG, Bosch J, et al. Portal cholangiopathy: radiological classification and natural history. Gut. 2011;60:853–60 A longitudinal study dissecting the natural history of the initial course of portal cavernoma cholangiopathy and its relationship with bile duct dilatation.CrossRef •• Llop E, de Juan C, Seijo S, Garcia-Criado A, Abraldes JG, Bosch J, et al. Portal cholangiopathy: radiological classification and natural history. Gut. 2011;60:853–60 A longitudinal study dissecting the natural history of the initial course of portal cavernoma cholangiopathy and its relationship with bile duct dilatation.CrossRef
7.
Zurück zum Zitat • Puri P. Portal cavernoma cholangiopathy: Is it compression by collaterals or ischemic injury to bile ducts during portal vein thrombosis ? J Clin Exp Hepatol. 2014;4:S27–33 An excellent overview of the hypotheses on pathogenesis.CrossRef • Puri P. Portal cavernoma cholangiopathy: Is it compression by collaterals or ischemic injury to bile ducts during portal vein thrombosis ? J Clin Exp Hepatol. 2014;4:S27–33 An excellent overview of the hypotheses on pathogenesis.CrossRef
8.
Zurück zum Zitat • Rameshbabu CS, Sharma M. Biliary tract anatomy and its relationship with venous drainage. J Clin Exp Hepatol. 2014;4:S18–26 An excellent overview on the anatomy of the biliary system and its portal venous drainage.CrossRef • Rameshbabu CS, Sharma M. Biliary tract anatomy and its relationship with venous drainage. J Clin Exp Hepatol. 2014;4:S18–26 An excellent overview on the anatomy of the biliary system and its portal venous drainage.CrossRef
9.
Zurück zum Zitat Sharma M, Rameshbabu CS. Portal cavernoma cholangiopathy: an endoscopic ultrasound based approach. J Clin Exp Hepatol. 2014;4:S53–61.CrossRef Sharma M, Rameshbabu CS. Portal cavernoma cholangiopathy: an endoscopic ultrasound based approach. J Clin Exp Hepatol. 2014;4:S53–61.CrossRef
10.
Zurück zum Zitat Takagi T, Irisawa A, Shibukawa G, Hikichi T, Obara K, Ohira H. Intraductal ultrasonographic anatomy of biliary varices in patients with portal hypertension. Endosc Ultrasound. 2015;4:44–51.CrossRef Takagi T, Irisawa A, Shibukawa G, Hikichi T, Obara K, Ohira H. Intraductal ultrasonographic anatomy of biliary varices in patients with portal hypertension. Endosc Ultrasound. 2015;4:44–51.CrossRef
11.
Zurück zum Zitat • Rai GP, Nijhawan S, Madhu MP, Sharma SS, Pokharna R. Comparative evaluation of magnetic resonance cholangiopancreatography/magnetic resonance splenoportography and endoscopic ultrasound in the diagnosis of portal cavernoma cholangiopathy. Indian J Gastroenterol. 2015;34:442–7 A study showing the increased sensitivity of endoscopic ultrasound to detect dilated portal collaterals within the wall of the bile ducts.CrossRef • Rai GP, Nijhawan S, Madhu MP, Sharma SS, Pokharna R. Comparative evaluation of magnetic resonance cholangiopancreatography/magnetic resonance splenoportography and endoscopic ultrasound in the diagnosis of portal cavernoma cholangiopathy. Indian J Gastroenterol. 2015;34:442–7 A study showing the increased sensitivity of endoscopic ultrasound to detect dilated portal collaterals within the wall of the bile ducts.CrossRef
12.
Zurück zum Zitat Oh HC, Akisik F, Sherman S. Single-operator cholangioscopy for the diagnosis of portal cavernoma cholangiopathy. Clin Gastroenterol Hepatol. 2017;15:e57–8.CrossRef Oh HC, Akisik F, Sherman S. Single-operator cholangioscopy for the diagnosis of portal cavernoma cholangiopathy. Clin Gastroenterol Hepatol. 2017;15:e57–8.CrossRef
13.
Zurück zum Zitat Dhiman RK, Puri P, Chawla Y, Minz M, Bapuraj JR, Gupta S, et al. Biliary changes in extrahepatic portal vein obstruction: compression by collaterals or ischemic. Gastrointest Endosc. 1999;50:646–52.CrossRef Dhiman RK, Puri P, Chawla Y, Minz M, Bapuraj JR, Gupta S, et al. Biliary changes in extrahepatic portal vein obstruction: compression by collaterals or ischemic. Gastrointest Endosc. 1999;50:646–52.CrossRef
14.
Zurück zum Zitat •• Condat B, Vilgrain V, Asselah T, O’Toole D, Rufat P, Zappa M, et al. Portal cavernoma-associated cholangiopathy: a clinical and MR cholangiography coupled with MR portography imaging study. Hepatology. 2003;37:1302–8 The study showing, by confronting MR cholangiography and MR portography, that bile duct irregularities at cholangiography are related to impinging on the bile duct lumen by the portoportal collaterals.CrossRef •• Condat B, Vilgrain V, Asselah T, O’Toole D, Rufat P, Zappa M, et al. Portal cavernoma-associated cholangiopathy: a clinical and MR cholangiography coupled with MR portography imaging study. Hepatology. 2003;37:1302–8 The study showing, by confronting MR cholangiography and MR portography, that bile duct irregularities at cholangiography are related to impinging on the bile duct lumen by the portoportal collaterals.CrossRef
15.
Zurück zum Zitat • Vibert E, Azoulay D, Aloia T, Pascal G, Veilhan LA, Adam R, et al. Therapeutic strategies in symptomatic portal biliopathy. Ann Surg. 2007;246(1):97–104 A landmark retrospective survey on surgical therapy.CrossRef • Vibert E, Azoulay D, Aloia T, Pascal G, Veilhan LA, Adam R, et al. Therapeutic strategies in symptomatic portal biliopathy. Ann Surg. 2007;246(1):97–104 A landmark retrospective survey on surgical therapy.CrossRef
16.
Zurück zum Zitat • Agarwal AK, Sharma D, Sing S, Agarwal S, Girish SP. Portal biliopathy: a study of 39 surgically treated patients. HPB. 2011;13:33–9 Another landmark retrospective survey on surgical therapy.CrossRef • Agarwal AK, Sharma D, Sing S, Agarwal S, Girish SP. Portal biliopathy: a study of 39 surgically treated patients. HPB. 2011;13:33–9 Another landmark retrospective survey on surgical therapy.CrossRef
17.
Zurück zum Zitat Dhiman RK, Singh P, Duseja A, et al. Pathogenesis of portal hypertensive biliopathy (PHB) is it compression by collaterals or ischemia? (Abstract). J Gastroenterol Hepatol. 2006;21:A506. Dhiman RK, Singh P, Duseja A, et al. Pathogenesis of portal hypertensive biliopathy (PHB) is it compression by collaterals or ischemia? (Abstract). J Gastroenterol Hepatol. 2006;21:A506.
18.
Zurück zum Zitat Huston DG, Pereira R, Zeppa R, Levy J, Schiff ER, Fink P. The fate of esophageal varices following selective distal splenorenal shunt. Ann Surg. 1976;183:496–501.CrossRef Huston DG, Pereira R, Zeppa R, Levy J, Schiff ER, Fink P. The fate of esophageal varices following selective distal splenorenal shunt. Ann Surg. 1976;183:496–501.CrossRef
19.
Zurück zum Zitat Slieker JC, Farid WRR, van Eijck CHJ, Lange JF, van Bommel J, Metselaar HJ, et al. Significant contribution of the portal vein to blood flow through the common bile duct. Ann Surg. 2012;255:523–7.CrossRef Slieker JC, Farid WRR, van Eijck CHJ, Lange JF, van Bommel J, Metselaar HJ, et al. Significant contribution of the portal vein to blood flow through the common bile duct. Ann Surg. 2012;255:523–7.CrossRef
20.
Zurück zum Zitat • Chiu B, Superina R. Extrahepatic portal vein thrombosis is associated with an increased incidence of cholelithisasis. J Pediatr Surg. 2004;39:1059–61 The first and best documented study on an increased prevalence of choletlithiasis in patients with portal cavernoma cholangiopathy.CrossRef • Chiu B, Superina R. Extrahepatic portal vein thrombosis is associated with an increased incidence of cholelithisasis. J Pediatr Surg. 2004;39:1059–61 The first and best documented study on an increased prevalence of choletlithiasis in patients with portal cavernoma cholangiopathy.CrossRef
21.
Zurück zum Zitat Harmanci A, Bayraktar Y. How can portal vein cavernous transformation cause chronic incomplete biliary obstruction? World J Gastroenterol. 2012;18:3375–8.CrossRef Harmanci A, Bayraktar Y. How can portal vein cavernous transformation cause chronic incomplete biliary obstruction? World J Gastroenterol. 2012;18:3375–8.CrossRef
22.
Zurück zum Zitat • Jabeen S, Robani I, Choh NA, Ashraf O, Shaheen F, Gojwari T, et al. Spectrum of biliary abnormalities in portal cavernoma cholangiopathy (PCC) secondary to idiopathic extrahepatic portal vein obstruction (EHVPO) – a prospective magnetic resonance cholangiopancreatography (MRCP) based study. Br J Radiol. 2016;89:2016036 A comprehensive MR study on biliary anomalies in patients with portal cavernoma.CrossRef • Jabeen S, Robani I, Choh NA, Ashraf O, Shaheen F, Gojwari T, et al. Spectrum of biliary abnormalities in portal cavernoma cholangiopathy (PCC) secondary to idiopathic extrahepatic portal vein obstruction (EHVPO) – a prospective magnetic resonance cholangiopancreatography (MRCP) based study. Br J Radiol. 2016;89:2016036 A comprehensive MR study on biliary anomalies in patients with portal cavernoma.CrossRef
23.
Zurück zum Zitat Eto T. Gallstone formation in dogs after selective occlusion of the portal vein branches. Jpn J Surg. 1988;18:268–75.CrossRef Eto T. Gallstone formation in dogs after selective occlusion of the portal vein branches. Jpn J Surg. 1988;18:268–75.CrossRef
24.
Zurück zum Zitat • Shukla A, Gupte A, Kavir V, Dhore P, Bhatia S. Long term outcomes of patients with significant biliary obstruction due to portal cavernoma cholangiopathy and extrahepatic portal vein obstruction (EHVPO) with no shuntable veins. J Clin Exp Hepatol. 2017;7:328–33 One of the rare papers with prolonged follow-up of patients with portal cholangiopathy treated in a conservative manner because no shunt surgery was deemed feasible. CrossRef • Shukla A, Gupte A, Kavir V, Dhore P, Bhatia S. Long term outcomes of patients with significant biliary obstruction due to portal cavernoma cholangiopathy and extrahepatic portal vein obstruction (EHVPO) with no shuntable veins. J Clin Exp Hepatol. 2017;7:328–33 One of the rare papers with prolonged follow-up of patients with portal cholangiopathy treated in a conservative manner because no shunt surgery was deemed feasible. CrossRef
25.
Zurück zum Zitat Adachi Y, Kamisako T, Yamamoto T. The effects of temporary occlusion of the superior mesenteric vein or splenic vein on biliary bilirubin and bile excretion in rats. J Lab Clin Med. 1991;118:261–8.PubMed Adachi Y, Kamisako T, Yamamoto T. The effects of temporary occlusion of the superior mesenteric vein or splenic vein on biliary bilirubin and bile excretion in rats. J Lab Clin Med. 1991;118:261–8.PubMed
26.
Zurück zum Zitat Duseja A. Portal cavernoma cholangiopathy – clinical characteristics. J Clin Exp Hepatol. 2014;4:S34–6.PubMed Duseja A. Portal cavernoma cholangiopathy – clinical characteristics. J Clin Exp Hepatol. 2014;4:S34–6.PubMed
27.
Zurück zum Zitat •• Franceschet I, Zanetto A, Ferrarese A, Burra P, Senzolo M. Therapeutic approaches for portal biliopathy: a systematic review. World J Gastroenterol. 2016;22:9909–20 The only systematic review on therapy for portal cavernoma cholangiopathy.CrossRef •• Franceschet I, Zanetto A, Ferrarese A, Burra P, Senzolo M. Therapeutic approaches for portal biliopathy: a systematic review. World J Gastroenterol. 2016;22:9909–20 The only systematic review on therapy for portal cavernoma cholangiopathy.CrossRef
28.
Zurück zum Zitat Khare R, Sikora SS, Srikanth G, Choudhuri G, Saraswat VA, Kumar A, et al. Extrahepatic portal venous obstruction and obstructive jaundice: approach to management. J Gastroenterol Hepatol. 2005;20:56–61.CrossRef Khare R, Sikora SS, Srikanth G, Choudhuri G, Saraswat VA, Kumar A, et al. Extrahepatic portal venous obstruction and obstructive jaundice: approach to management. J Gastroenterol Hepatol. 2005;20:56–61.CrossRef
29.
Zurück zum Zitat Sharma BC, Singh RP, Narasimhan KL, Rao KLN, Mitra SK, Dilawari JB. Effect of shunt surgery on spleen size, portal pressure and oesophageal varices in patients with non-cirrhotic portal hypertension. J Gastroenterol Hepatol. 1997;12:582–4.CrossRef Sharma BC, Singh RP, Narasimhan KL, Rao KLN, Mitra SK, Dilawari JB. Effect of shunt surgery on spleen size, portal pressure and oesophageal varices in patients with non-cirrhotic portal hypertension. J Gastroenterol Hepatol. 1997;12:582–4.CrossRef
30.
Zurück zum Zitat Deltenre P, Valla DC. Ischemic cholangiopathy. J Hepatol. 2006;44:806–17.CrossRef Deltenre P, Valla DC. Ischemic cholangiopathy. J Hepatol. 2006;44:806–17.CrossRef
Metadaten
Titel
Portal Cavernoma Cholangiopathy
verfasst von
Dominique-Charles Valla
Publikationsdatum
05.10.2018
Verlag
Springer US
Erschienen in
Current Hepatology Reports / Ausgabe 4/2018
Elektronische ISSN: 2195-9595
DOI
https://doi.org/10.1007/s11901-018-0430-x

Weitere Artikel der Ausgabe 4/2018

Current Hepatology Reports 4/2018 Zur Ausgabe

Hepatic Cancer (A Singal and A Mufti, Section Editors)

Current State of Immunotherapy for HCC—Supporting Data and Toxicity Management

Fatty Liver Disease (Z Younossi, Section Editor)

The Clinical and Economic Burden of Nonalcoholic Steatohepatitis

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.